Scientists hunt for clues to make cancer drugs work better
NCT ID NCT03356470
Summary
This small study aimed to find better ways to predict which patients with advanced melanoma will respond to immunotherapy drugs like pembrolizumab. Researchers used special scans and took blood and tumor samples from 5 patients before and during treatment. The goal was to identify biological 'biomarkers' that could tell doctors early on if the treatment is working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.